期刊文献+

5-氨基水杨酸pH依赖-菌群触发型结肠定位给药系统的体外释放性能 被引量:5

Study on the release of 5-aminosalicylic acid colon-specific delivery controlled by pH and bacteria in vitro
原文传递
导出
摘要 目的研究5-氨基水杨酸(5-ASA)pH依赖-菌群触发型结肠定位给药系统的体外释放性能。方法将5-ASA装于以瓜尔豆胶和Eudragit S 100包膜的胶囊中,采用Diamonsil TM-C_(18)(250mm×4.6mm,5μm)色谱柱,柱温25℃,流速1.0mL·min^(-1),检测波长为240nm,测定其在pH 1.2 HCl、pH6.8和7.4 PBS溶液中的体外释放性能。结果 5-ASA胶囊的3批样品在pH 1.2 HCl、pH 6.8 PBS溶液中几乎不释药,在pH 7.4 PBS溶液中有释药。增重34%样品在pH 7.2 PBS和pH 7.2 PBS+β-甘露聚糖酶的溶液中,释放无明显差异;而增重44%样品有差异。结论用瓜尔豆胶和Eudragit S 100包膜的5-ASA胶囊具有良好的结肠定位释药效果。 AIM To study the release of 5-aminosalicylic acid(5-ASA) colon-specific delivery controlled by pH and bacteria in vitro.METHODS 5-ASA was filled in the capsules and the capsules then were coated with guar gum and Eudragit S 100.The chromatographic column was Diamonsil TM-C_(18)(250 mm×4.6 mm,5μm),the detection wavelength was 240 nm,and the flow rate was 1.0 mL·min^(-1).RESULTS Data obtained showed that the capsules were not released in pH 1.2 HQ and pH 6.8 PBS,but released in pH 7.4 PBS.There were no significant differences between pH 7.2 PBS and pH 7.2 PBS withβ-mannanase when the capsules were weighted gain 34%.There were differences when the capsules were weighted gain 44%.CONCLUSION 5-ASA capsules coated with guar gum and Eudragit S 100 have better effects to release the drugs in colon.
出处 《中国临床药学杂志》 CAS 2011年第2期69-73,共5页 Chinese Journal of Clinical Pharmacy
基金 上海交通大学医工交叉基金(编号090YG016)
关键词 5-氨基水杨酸 口服结肠定位给药系统 体外释放度 5-aminosalicylic acid oral colon-specific drug delivery system release rate in vitro
  • 相关文献

参考文献5

  • 1徐彦,齐宪荣,魏树礼.5-氨基水杨酸结肠定位给药酶控释小丸的制备与体外释放[J].中国新药杂志,2003,12(6):441-445. 被引量:8
  • 2国家药典委员会.中华人民共和国药典(二部)[S].北京:化学工业出版社,2005,附录ⅪA:79-81.
  • 3曹明成,沈善,陈斌,王菊.5-氨基水杨酸栓的制备及质量标准[J].安徽医科大学学报,2003,38(3):194-196. 被引量:2
  • 4Cohen R. Evolutionary advances in the deliveryatr, inosalicylates forthe treatment d" ulcerative colitis[ J ]. Aliment Pharmacol Ther,2(X)6,2d. (3):465.
  • 5Ibekwe VC,Khela MK,Evans DF,et al. A new concept in colonic drug targeting: a combined pH-responsive and bacterially-triggered ,trug delivery technology[J]. Aliment Pharmacol Ther,2008,28(7) :911.

二级参考文献15

  • 1王春龙,陈如柳,朱梦秋,张提勇.口服结肠靶向给药在疾病治疗中的应用[J].中国药学杂志,1997,32(1):1-3. 被引量:12
  • 2.GB/F15683—1995.稻米直链淀粉含量的测定[S].,1995..
  • 3徐惠南.缓释包衣与小丸成型技术[A].陆彬.药物新剂型与新技术[C].北京:人民卫生出版社,1998.264.
  • 4.USP24,2000:1046-8.[S].,2000..
  • 5Newton JM, Leong CW, Basit AW, et al. The formation of colonic digestible films of amylose and ethylcellulose form aqueous dispersions at temperatures below 37℃ [J ]. Eur J Pharm Biopharm, 2002,54 (3) : 291 - 297.
  • 6Lee F, Abdual W, Michael J, et al. The properties of amyloseethyleellulose films cast from organic-based solvents as potential coatings for colonic delivery[J]. Eur J Pharrn Sci, 2000, 11(2) : 133-139.
  • 7Milojevic S, Newton JM,Cummings JH, et al. Amylose as a coating for drug delivevy to the colon:Preparation and in vitro evaluation using 5-aminosalicylic acid pellets[J ]. J Controlled Release,1996,38 ( 1 ) : 75 - 84.
  • 8Newton JM, Leong CW. Low temperature coating [ P ].WO99253225,1999 - 11.
  • 9Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery[J]. Int J Pharm ,2001,224( 1 - 2) : 19 - 38.
  • 10Palviainen P, Heinamaki J, Myllarinen P, et al. Com starches as film formers in aqueous-based film coating [ J ]. Pharm Dev Technol,2001,6(3) :353 - 61.

共引文献11

同被引文献75

  • 1韦镔倩,赵培庄,王珍,黄俊,施佳玲,黄雪.白藜芦醇联合5-氨基水杨酸对脂多糖诱导的HT-29细胞损伤模型紧密连接蛋白表达的影响[J].广西医科大学学报,2023,40(3):357-361. 被引量:3
  • 2方瑜,曹德英.美沙拉嗪结肠靶向微丸的制备和体外评价[J].中国现代应用药学,2006,23(S1):632-635. 被引量:5
  • 3赖俊英,李文静,王红军,涂克华,王利群.结肠靶向偶氮高分子的合成及其体外降解性能[J].高分子学报,2007,17(1):8-14. 被引量:5
  • 4Jain SK,Jain A.Target-speeific drug release to the colon[J]. Expert Opin Drug Deliv,2008,5(5):483--498.
  • 5Prajapati VD, Jani GK, Moradiya NG, et al. Pharmaceutical applications of various natural gums, mucilages and their modified forms [J]. Carbohydrate Polymers, 2013, 92 ( 2 ) : 1685--1699.
  • 6Sharma R, Rawal RK, Malhotra M, et ah Design, synthesis and ex-vivo release studies of colon-specific polyphosphazene- anticancer drug conjugates[J].Bioorg Med Chem, 2014, 22 (3) :1104--1114.
  • 7Kenawy ER, Aly ES, Abdel-Hay FI, et ah Synthesis and microbial degradation of azopolymers for possible applications for colon specific drug delivery I [J]. J Saudi Chem Soc, 2011,15(4) :327--335.
  • 8Popat A, Ross BP, Liu J, et al. Enzyme-responsive controlled release of eovalently bound prodrug from functional mesoporous silica nanospheres[J].Angew Chem Int Ed Engl,2012,51(50):12486--12489.
  • 9Omwancha WS, Mallipeddi R, Valle BL, et al. Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA[J].Int J Pharm,2013,441(1/2) :343--351.
  • 10Mennini N, Furlanetto S, Cirri M, et al. Quality by design approach for developing chitosan microspheres for colon delivery of eelecoxib-hydroxypropyl-13-cyclodext rin-PVP complex[J]. Eur J Pharm Biopharm, 2012,80 ( 1 ) . 67-- 75.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部